Empagliflozin reduces body weight and indices of adipose distribution in patients with type 2 diabetes mellitus

AIMS: To determine the effects of empagliflozin on adiposity indices among patients with type 2 diabetes mellitus. METHODS: Changes in weight, waist circumference, estimated total body fat, index of central obesity and visceral adiposity index were assessed using analysis of covariance and testing o...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Diab Vasc Dis Res
Auteurs principaux: Neeland, Ian J, McGuire, Darren K, Chilton, Robert, Crowe, Susanne, Lund, Søren S, Woerle, Hans J, Broedl, Uli C, Johansen, Odd Erik
Format: Artigo
Langue:Inglês
Publié: SAGE Publications 2016
Sujets:
Original Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4768401/
https://ncbi.nlm.nih.gov/pubmed/26873905
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1479164115616901
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires